SEGMENT INFORMATION (Tables)

12 Months Ended

Oct. 31, 2016

Revenue from External Customer [Line Items]

The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.



	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total Segments
	(in millions)
Year ended October 31, 2016:
Total net revenue	$	2,073	$	709	$	1,420	$	4,202
Income from operations	$	429	$	114	$	316	$	859
Depreciation expense	$	36	$	31	$	28	$	95
Share-based compensation expense	$	29	$	10	$	21	$	60
Year ended October 31, 2015:
Total net revenue	$	2,046	$	662	$	1,330	$	4,038
Income from operations	$	380	$	88	$	299	$	767
Depreciation expense	$	27	$	37	$	34	$	98
Share-based compensation expense	$	27	$	9	$	18	$	54
Year ended October 31, 2014:
Total net revenue	$	2,078	$	663	$	1,307	$	4,048
Income from operations	$	369	$	93	$	301	$	763
Depreciation expense	$	29	$	43	$	33	$	105
Share-based compensation expense	$	29	$	9	$	18	$	56

Reconciliation of segment results to total enterprise results

The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:



	Years Ended October 31,
	2016			2015			2014
	(in millions)
Total reportable segments' income from operations	$	859		$	767		$	763
Restructuring and business exit related costs	(11		)	(12		)	(66		)
Asset Impairments	(4		)	(3		)	(4		)
Transformational programs	(38		)	(56		)	(29		)
Amortization of intangibles	(152		)	(156		)	(189		)
Acquisition and integration costs	(41		)	(13		)	(11		)
Acceleration of share-based compensation expense related to workforce reduction	—			(2		)	(1		)
One-time and pre-separation costs	—			—			(14		)
Pension curtailment gain	16			—			—
Impairment of loans	(7		)	—			—
Other	(7		)	(3		)	10
Interest Income	11			7			9
Interest Expense	(72		)	(66		)	(110		)
Other income (expense), net	(10		)	17			(89		)
Unallocated corporate charges	—			—			(40		)
Income before taxes, as reported	$	544		$	480		$	229

Assets and capital expenditures directly managed by each segment

The following table presents assets and capital expenditures directly managed by each segment. Unallocated assets primarily consist of cash, cash equivalents, accumulated amortization of other intangibles and other assets.



	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total Segments
	(in millions)
As of October 31, 2016:
Assets	$	1,687	$	1,960	$	1,082	$	4,729
Capital expenditures	$	53	$	41	$	45	$	139
As of October 31, 2015:
Assets	$	1,539	$	2,027	$	1,008	$	4,574
Capital expenditures	$	28	$	33	$	37	$	98

The following table reconciles segment assets to Agilent's total assets:



	October 31,
	2016		2015
	(in millions)
Total reportable segments' assets	$	4,729	$	4,574
Cash, cash equivalents and short-term investments	2,289		2,003
Short-term restricted cash and cash equivalents	—		242
Prepaid expenses	92		105
Investments	135		86
Long-term and other receivables	92		104
Other	465		365
Total assets	$	7,802	$	7,479

Revenue by product category

The following table represents total revenue by product category:



	Years Ended October 31,
	2016		2015		2014
	(in millions)
Instrumentation	$	1,871	$	1,827	$	1,839
Analytical lab services	910		843		831
Analytical lab consumables	510		489		476
Diagnostics and genomics solutions	709		662		663
Informatics and other	202		217		239
Total	$	4,202	$	4,038	$	4,048

Revenue and assets by geographic areas

The following table presents summarized information for net revenue and long-lived assets by geographic region. Revenues from external customers are generally attributed to countries based upon the customer's location. Long lived assets consist of property, plant, and equipment, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of rest of Asia and Europe.



	United States		China		Rest of the World		Total
	(in millions)
Net revenue:
Year ended October 31, 2016	$	1,251	$	821	$	2,130	$	4,202
Year ended October 31, 2015	$	1,206	$	633	$	2,199	$	4,038
Year ended October 31, 2014	$	1,019	$	543	$	2,486	$	4,048



	United States		Germany		Rest of the World		Total
	(in millions)
Long-lived assets:
October 31, 2016	$	449	$	89	$	266	$	804
October 31, 2015	$	391	$	64	$	315	$	770